Sign Up For Mailing List Button

Donate to Genetic Alliance

Disease Search Button

NETS - IND Application

Facebook icon
Google+ icon
Twitter icon
LinkedIn icon
Del.icio.us icon
Digg icon
  • Partnerships
  • Publications
  • Multimedia
  • Worksheets
  • Guides
  • Toolkits
  • Databases
  • Services

What is an IND application and why is it important in drug development?

An investigational new drug (IND) application is an application that must be submitted to the FDA to obtain permission to begin a clinical trial. An IND application is submitted by the clinical trial sponsor and must include documentation of the pharmacology and toxicology studies demonstrating that the compound has proven safe in animal testing. It will also contain manufacturing information, clinical protocols for the proposed clinical trial, and information on the study investigators and staff. This report must be submitted to the FDA before human testing may begin.

In Europe, a clinical trial authorization (CTA) application must be submitted prior to beginning clinical trials. Applications are submitted to National Health Agencies in each country where trials will be conducted by drug sponsors or their representatives. Clinical trial sponsors must be established within the European Community, or have a legal representative who is. Like INDs, CTAs must include documentation of pharmacology and toxicology studies, manufacturing information, clinical protocols and information on study investigators and staff.

Testimonials: How we did it

Content not yet available for this section.


 

Twitter icon
Facebook icon
LinkedIn icon
Google+ icon
YouTube icon
RSS icon

4301 Connecticut Ave NW, Suite 404, Washington DC 20008-2369 | Tel: 202.966.5557 | Fax: 202.966.8553 | EIN 52-1571905

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 License.